Literature DB >> 10129839

QALYs (quality-adjusted life-years) versus HYEs (healthy years equivalents)

A J Culyer1, A Wagstaff.   

Abstract

This paper explores the claim that QALYs are liable to misrepresent consumer preferences and hence lead to decision-makers choosing options which are not those preferred by the public. It also considers the claim that HYEs do not suffer from this defect. We argue that none of the examples offered to date demonstrate the alleged tendency of QALYs to misrepresent preferences. We also show that HYEs are identical to QALY scores obtained from a time tradeoff experiment and therefore that the assumptions about preferences underlying HYEs are just as restrictive as those underlying TTO-based QALYs.

Mesh:

Year:  1993        PMID: 10129839     DOI: 10.1016/0167-6296(93)90014-6

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  5 in total

1.  Efficient use of health care resources: the interaction between improved health and reduced health related income loss.

Authors:  Michael Hoel
Journal:  Int J Health Care Finance Econ       Date:  2002-11

2.  Canadian guidelines for economic evaluation of pharmaceuticals. Canadian Collaborative Workshop for Pharmacoeconomics.

Authors:  G W Torrance; D Blaker; A Detsky; W Kennedy; F Schubert; D Menon; P Tugwell; R Konchak; E Hubbard; T Firestone
Journal:  Pharmacoeconomics       Date:  1996-06       Impact factor: 4.981

3.  Assessing the benefits of health care: how far should we go?

Authors:  M Ryan; P Shackley
Journal:  Qual Health Care       Date:  1995-09

Review 4.  QALYs and mental health care.

Authors:  D Chisholm; A Healey; M Knapp
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1997-02       Impact factor: 4.328

Review 5.  The Short-Form 36 (SF-36) Health Survey and its use in pharmacoeconomic evaluation.

Authors:  J Brazier
Journal:  Pharmacoeconomics       Date:  1995-05       Impact factor: 4.981

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.